Roger Mulet-Lazaro

15PUBLICATIONS
112CO-AUTHORS
Medical mycologyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Microelectromechanical systems (MEMS)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 08, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|Apr 16, 2025
One for All and All for One: New Insights into Enhancers Driving MYC Dysregulation.

Roger Mulet-Lazaro, Ruud Delwel

|Mar 31, 2025
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Etienne Sollier, Anna Riedel, Umut H Toprak

|Mar 26, 2025
Hematological phenotypes in GATA2 deficiency syndrome arise from aging, maladaptation to proliferation, and somatic events.

Juncal Fernandez-Orth, Cansu Koyunlar, Julia M Weiss

|Nov 21, 2024
The co-receptor Neuropilin-1 enhances proliferation in inv(16) acute myeloid leukemia via VEGF signaling.

Mahesh Hegde, Mohd H Ahmad, Roger Mulet Lazaro

|Aug 02, 2024
Oncogenic Enhancers in Leukemia.

Roger Mulet-Lazaro, Ruud Delwel

Pageof 3